Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
Clinical trial NCT05804227 · RECRUITING
Trial details
- NCT number
- NCT05804227
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-20
- Primary completion
- 2027-09-22
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.